Effect of continued imatinib (IM) in pts with detectable BCR-ABL after ≥ 2 years on study on deep molecular responses (MR): 36-month update from ENESTcmr. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Spector, Nelson
  • Clementino, Nelma Cristina D
  • Dorlhiac-Llacer, Pedro Enrique
  • Leber, Brian
  • Hughes, Timothy P
  • Cervantes, Francisco
  • Schwarer, Anthony P
  • Forrest, Donna L
  • Kamel-Reid, Suzanne
  • Bendit, Israel
  • Acharya, Sandip
  • Collins, LaTonya
  • Dalal, Darshan
  • Lipton, Jeffrey H

publication date

  • May 20, 2014